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ABSTRACT
Theexosomeisacomplex of30!50 exoribonucleases
which is involved in many RNA metabolic processes.
To regulate these functions distinct proteins are
believed to recruit the exosome to specific substrate
RNAs.Here,wedemonstratethatM-phasephosphop-
rotein 6 (MPP6), a protein reported previously to
co-purify with the TAP-tagged human exosome,
accumulates in the nucleoli of HEp-2 cells and asso-
ciates with a subset of nuclear exosomes as evid-
enced by co-immunoprecipitation and biochemical
fractionation experiments. In agreement with its nuc-
leolar accumulation, siRNA-mediated knock-down
experiments revealed that MPP6 is involved in the
generation of the 30 end of the 5.8S rRNA. The
accumulation of the same processing intermediates
after reducing the levels of either MPP6 or exosome
components stronglysuggeststhat MPP6 is required
for the recruitment of the exosome to the pre-rRNA.
Interestingly,MPP6appearedtodisplayRNA-binding
activity in vitro with a preference for pyrimidine-rich
sequences, and to bind to the ITS2 element of pre-
rRNAs. Our data indicate that MPP6 is a nucleolus-
specific exosome co-factor required for its role in
the maturation of 5.8S rRNA.
INTRODUCTION
The exosome complex consists of 30!50 exoribonucleases
and putative RNA-binding proteins and was originally iden-
tiﬁed in yeast during a study investigating the 30 end matura-
tion of 5.8S rRNA (1,2). Since, the yeast exosome has also
been demonstrated to be required for the processing of small
nuclear RNA (snRNA), small nucleolar RNA (snoRNA) and
the degradation of aberrant pre-mRNAs in the nucleus (3–6),
as well as the turnover of mRNAs in the cytoplasm (7–11).
In 1999, the yeast exosome components Rrp6p and Rrp45p
were found to be homologous to the human PM/Scl-100 and
PM/Scl-75 autoantigens. Moreover, human homologues of the
yeast exosome components Rrp4p, Rrp40p, Rrp41p and
Rrp46p were shown to physically interact with the polymy-
ositis/scleroderma (PM/Scl) complex, an autoantigenic multi-
protein complex containing PM/Scl-100 and PM/Scl-75,
demonstrating that the yeast exosome and the human PM/
Scl complex are very similar (12,13). Nine components of
the human exosome were shown to be shared by the nuclear
and cytoplasmic forms of the complex and are collectively
referred to as the core exosome (9). Six of these nine proteins
(hRrp41p, hRrp42p, hRrp46p, hMtr3p, OIP2 and PM/Scl-75)
show homology to the Escherichia coli exonuclease RNase
PH, the three other core exosome components (hRrp4p,
hRrp40p and hCsl4p) contain a putative S1 RNA-binding
domain. The exosome core components assemble into a
doughnut-like structure, characterized by a six-membered
ring formed by the RNase PH subunits (14–16).
In the nucleolus, three out of the four rRNA molecules are
transcribed as a single precursor by RNA polymerase I. This
precursor is processed by a series of endo- and exonucleolytic
cleavages to form the mature 18S, 5.8S and 25S/28S rRNAs
[reviewed in ref. (17)]. In yeast, deletion of core exosome
components as well as the nuclear exosome-associated co-
factor Mtr4p/Dob1p leads to accumulation of both precursor
5.8S rRNAs extended at their 30 ends and 50ETS fragments
(1,3,6,12,18). Moreover, deletion of one of the yeast exosome
components prevents cleavage at the early pre-rRNA cleavage
sites A0, A1, A2 and A3, leading to depletion of mature 18S
and 25S rRNAs (3,19). These processing steps do not require
30!50 exoribonuclease activity implying an indirect require-
ment for the exosome. Also upon depletion of the nuclear
exosome-associated exoribonuclease Rrp6p and co-factor
Rrp47p, defects in rRNA processing are observed
(5,6,20,21). However, the effects are distinct from depletion
of core exosome components, indicating that the functions of
Rrp6p and the core exosome are not identical.
Four yeast exosome components and two human exosome
components have proven 30!50 exonuclease activity, while
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doi:10.1093/nar/gki982the other exosome components with a RNase PH domain are
predicted to possess such an activity (1,22,23). Besides the
core exosome components, several additional exosome-
associated proteins have been identiﬁed and these are most
probably involved in the recruitment of the exosome to spe-
ciﬁc classes of substrate RNAs, its association with other
processing complexes, or the modulation of its activity. An
early identiﬁed exosome-associated protein, PM/Scl-100
(Rrp6p in yeast), is homologous to E.coli RNase D.
KIAA0052/hMtr4p is a putative helicase and its yeast homo-
logue Dob1p/Mtr4p acts in concert with the exosome in the
processing of several types of nuclear RNA substrates. The
M-phase phosphoprotein 6 (MPP6) was found to co-purify
with the human exosome, when the latter was isolated via a
TAP-tag puriﬁcation approach (9). MPP6, which resides in the
nucleus of interphase cells, was originally identiﬁed by virtue
of its phosphorylation during mitosis (24). More recently,
MPP6 was shown to interact with KIAA0052/hMtr4p and
PM/Scl-100 using a yeast-two-hybrid approach (25). MPP6
is the only exosome-associated protein currently identiﬁed for
which no yeast counterpart is known.
Here we show that MPP6 is associated with a subset of
nuclear exosome complexes and that knock down of MPP6
leads to an accumulation of 30 end extended 5.8S rRNAs,
which are also accumulating upon knock down of PM/Scl-
100 and hRrp41p. Moreover, we show that MPP6 is a RNA-
binding protein in vitro, which is able to bind to (pre)-rRNAs
and preferentially binds to poly(C) and poly(U).
MATERIALS AND METHODS
cDNA cloning and recombinant protein expression
The human MPP6 cDNA (GenBank accession number:
NM_005792) was cloned by a PCR-based approach using a
placenta cDNA library and oligonucleotides MPP6-forward,
50-GCGGATCCGGAATTCAATGGCGGCCGAGAGAAAG-
AC-30, and MPP6-reverse, 50-GCCCCGGGTTATCTAGAA-
TCCTGGGGCTTTAAGAACA-30. The PCR products were
cloned into the pCR4-TOPO vector according the manufac-
turer’s procedure (Invitrogen) and the integrity of the resulting
construct was veriﬁed by DNA sequencing. In order to obtain
the N-terminally GST- or His6-tagged MPP6 protein, the
MPP6 open reading frame was cloned into pGEX-4T3
(AmershamPharmaciaBiotech)andpQE32 (Qiagen), respect-
ively. The tagged proteins were expressed in E.coli
BL21(DE3)pLysS and puriﬁed by afﬁnity chromatography
using either glutathione–Sepharose or an immobilized nickel
resin. The purity and quantity of the recombinant proteins
were determined by SDS–PAGE.
GST pull-down assay
For the analysis of protein–RNA interactions, 20 ml of
glutathione–Sepharose (Amersham Pharmacia Biotech)
beads (50% slurry) were washed three times with 200 mlo f
pull-down buffer 100 [PB-100: 20 mM HEPES–KOH, pH 7.6,
100 mM KCl, 0.5 mM EDTA, 0.05% NP-40, 1 mM DTT,
0.02% BSA, 0.5 mM phenylmethlysulfonyl ﬂuoride (PMSF)].
GSTorGST-MPP6( 1mg)wascoupledtothebeadsin200ml
of PB-100 by incubating at room temperature for 1 h under
continuous agitation. After centrifugation, the supernatant was
discarded and the beads were resuspended in 100 ml pull-down
buffer.
32P-labelled RNAs and 20 U RNasin were added and
the mixture was incubated for 1 h at 4 C under continuous
agitation. The beads were washed three times with PB-200
(composition like PB-100, but containing 200 mM KCl) and
the co-precipitating RNAs were extracted and analysed by
denaturing PAGE and autoradiography.
Generation and affinity purification of rabbit
anti-MPP6 antibodies
GST-MPP6 fusion protein was used to immunize rabbit M87.
The serum from rabbit M87 recognized recombinant His6-
MPP6 (data not shown). Anti-MPP6 antibodies were
afﬁnity-puriﬁed using His6-MPP6 recombinant protein
coupled to CNBr-activated Sepharose as described by the
manufacturer (Amersham Biosciences).
Preparation of HEp-2 cell extracts
Cytoplasmic and nuclear extracts were prepared from HEp-2
cells by resuspension of the harvested cells in lysis buffer
(25 mM Tris–HCl, pH 7.5, 150 mM KCl, 1 mM EDTA,
0.5 mM PMSF and 1 mM DTT), permeabilization by the
addition of digitonin to a ﬁnal concentration of 0.025%,
incubation for 10 min at room temperature, and centrifugation
at 1000 g. The supernatant was transferred to a new tube and is
referred to as the cytoplasmic fraction. After resuspending the
pellet in lysis buffer the nuclear extract was prepared by son-
ication using a Branson microtip. Both extracts were clariﬁed
by centrifugation at 12000 g for 10 min.
Immunoprecipitation
Per immunoprecipitation 10 ml of rabbit or patient serum was
coupled to 10 ml of protein A-agarose beads (Kem-En-Tec) in
IPP500 (0.5 M NaCl, 10 mM Tris–HCl, pH 8.0 and 0.05% NP-
40) at room temperature for 1 h. Beads were washed once with
IPP500 and twice with IPP150 (same as IPP500, but contain-
ing150mMNaCl).Subsequently,cellextract wasadded tothe
beads in IPP150 and incubated for 2 h at 4 C. After washing
the beads three times with IPP150 the precipitated proteins
wereelutedby theadditionofSDSsamplebuffer,separatedby
SDS–PAGE and blotted on nitrocellulose membranes.
Immunoblotting
For the detection of proteins on western blots, monoclonal
anti-hRrp4p antibody (culture supernatant) (ModiQuest,
Nijmegen, The Netherlands) and rabbit antisera were diluted
25- and 500-fold, respectively, in blocking buffer (5%
skimmed milk, phosphate-buffered saline (PBS) and 0.05%
NP-40). As secondary antibody, horseradish peroxidase-
conjugated rabbit anti-mouse IgG or swine anti-rabbit IgG
(Dako Immunoglobulins) were used after 2500-fold dilution
in blocking buffer. Bound antibodies were visualized by
chemiluminescence.
Northern blot analysis
Total RNA from HEp-2 cells was extracted 48 h after trans-
fection with or without siRNA using the TRIzol reagent (Invit-
rogen). Per sample 5 mg of total RNA was separated on a
denaturing 6% polyacrylamide gel, and after transfer to
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were hybridized with several
32P-labelled antisense RNA
probes in hybridization solution (6· SSC, 10· Denhardt’s,
100 mg/ml herring sperm DNA and 0.1% SDS). After over-
night incubation at 65 C, the blots were washed three times
with 2· SSC/0.1% SDS and analysed by autoradiography.
Oligonucleotides used in this study are 50ETS-1, 50-CGCG-
CGAGAGAACAGCAGGC-30, and 50ETS-2, 50-TCGTGAT-
TCTCGTCCATCCTCCGAC-30. The antisense 5.8S rRNA
probe was generated by linearizing a pGEM-3Zf(+) plasmid
containing a full-length 5.8S rRNA EcoRI–BamHI PCR prod-
uct with EcoRI and in vitro transcription by SP6 RNA poly-
merase. A pCR4-TOPO vector containing a XhoI–SalI PCR
product that covers the most 50 300 nt of the ITS2 was lin-
earized with XhoI and transcribed by T7 RNA polymerase to
yield a 337 nt antisense probe. The antisense ITS1 probe was
generated as described by Cohen et al. (26)
Transient transfection of HEp-2 cells and
fluorescence microscopy
For transfection, the cDNAs encoding hMtr3p and MPP6 were
cloned into EGFP vectors (Clontech) allowing expression of
the protein fused to the C-terminus of the EGFP protein. HEp-
2 cells were grown to 70% conﬂuency in DMEM containing
10% fetal calf serum (FCS) (DMEM+). For ﬂuorescence
microscopy  3 · 10
6 cells were transfected with 10 mgo f
plasmid DNA in 800 ml DMEM+ by electroporation at
260 V and 950 mF. The cells were seeded on coverslips
and cultured overnight. Subsequently, the cells were washed
twice with PBS and ﬁxed with 4% paraformaldehyde in PBS
for 20 min. After ﬁxation, cells were washed three times with
PBS and mounted with 50% glycerol in PBS. The EGFP-
fusion proteins were visualized by ﬂuorescence microscopy.
For siRNA transfection  3 · 10
5 cells were grown in
DMEM+. Per transfection 100 pmol of siRNA was transfected
into HEp-2 cells using Oligofectamine transfection reagent
(Invitrogen), as described by the manufacturer with the excep-
tion that during transfection 10% FCS was present in the
medium. As a control, cells were treated in the same way
but without adding siRNA to the transfection reagent.
siRNAs
Three MPP6 siRNA duplexes were designed based upon the
coding region of the human MPP6 sequence (GenBank acces-
sion number: NM_005792). The 21 nt siRNA duplexes con-
taining dTdT overhangs were purchased from IDT (Coralville,
IA): siMPP6-1, 50-GAGCACUGGUACUUGGAUUTT-30;
siMPP6-2, 50-CAGUAGAGCUUGAUGUGUCTT-30; and
siMPP6-3,50-GAUAUGAGACCUUGGUGGGTT-30.siRNAs
against human hRrp41p and PM/Scl-100 were described pre-
viously by LeJeune et al. (27). As a control an siRNA speciﬁc
for a melanoma cell marker, which is not expressed in the cell
lines used in this study, was used.
Glycerol gradient analysis
HEp-2 cell extracts were prepared as described above and
loaded on 5–40% (v/v) glycerol gradients prepared in gradient
buffer (25 mM Tris–HCl, pH 7.5, 150 mM KCl, 1 mM DTT
and 0.02% Triton X-100). Gradients were centrifuged in a
TH641 rotor (Sorvall) for 16 h at 25000 r.p.m. at 4 C and
subsequently 23 fractions per gradient were collected. The
proteins in these fractions were separated by SDS–PAGE
and transferred to nitrocellulose membranes for further
analysis.
RNase protection assay
Total RNA was extracted from HEp-2 cells transfected with
siRNAs as described above and resuspended in 100 mlo f
hybridization buffer (40 mM PIPES, pH6.4, 400 mM NaCl,
1 mM EDTA and 80% formamide). A radiolabelled antisense
ITS2 probe was synthesized by in vitro transcription, treated
with RNase-free DNase I (Invitrogen) for 15 min at 37 C and
after precipitation dissolved in hybridization buffer. Sub-
sequently, an excess of probe RNA was hybridized with
5 mg of total RNA overnight at 52 C. Free probe and non-
protected RNA was digested in ribonuclease digestion buffer
(10 mM Tris–HCl, pH7.4, 300 mM NaCl and 5 mM EDTA)
containing 40 mg/ml ribonuclease A and 2 mg/ml ribonuclease
T1 for 1 h at 37 C. The protected RNA was puriﬁed, dissolved
in RNA loading buffer and analysed on a 10% sequencing gel
and visualized by autoradiography.
RESULTS
The MPP6 protein localizes to the nucleoli and interacts
with the nuclear exosome
During TAP-tag puriﬁcations of the human exosome, MPP6
was found to co-fractionate with the human exosome (9). To
investigate whether MPP6 is truly associated with the human
exosome, its subcellular localization and interaction with the
human exosome complex were studied in more detail. HEp-2
cells were transiently transfected with constructs coding for
the EGFP-fusion proteins of MPP6 and hMtr3p as well as
EGFP alone as a control. The subcellular localization of
these proteins was examined by ﬂuorescence microscopy 24
h later. EGFP was found throughout the cell, whereas MPP6
and hMtr3p both accumulated in the nucleoli (Figure 1). As
has been observed before for other exosome core proteins, a
weak but signiﬁcant staining of the nucleoplasm was observed
for EGFP-hMtr3p in addition to the nucleolar staining
(Figure 1F).
To conﬁrm the association of MPP6 with the human exo-
some, co-immunoprecipitation experiments were performed
using a total HEp-2 cell extract and three anti-PM/Scl-
positive patient sera. These sera are strongly reactive with
the exosome components PM/Scl-75 and PM/Scl-100 and
to a lesser extent with other exosome components, but not
with the MPP6 protein. Three anti-PM/Scl-negative sera
served as controls (28,29). After immunoprecipitation, the
precipitated material was analysed by western blotting
using the rabbit anti-MPP6 antiserum. The results show that
MPP6 is precipitated with all anti-PM/Scl-positive sera
(Figure 2A, lanes 1–3) but not with the anti-PM/Scl-
negative sera (Figure 2A, lanes 4–6). In the reciprocal experi-
ment, the anti-MPP6 antiserum was used for immunoprecip-
itation of human exosome components from a total, nuclear
and cytoplasmic HEp-2 cell extract. Co-precipitation of the
exosome was monitored with a monoclonal antibody to the
human exosome component hRrp4p. As expected, an antibody
Nucleic Acids Research, 2005, Vol. 33, No. 21 6797to the core exosome component hRrp40p co-precipitated
hRrp4 from all three extracts (Figure 2B, lanes 4, 8 and
12). Anti-MPP6, however, co-precipitated hRrp4p from the
total as well as the nuclear extract (Figure 2B, lanes 3 and 7),
but not from the cytoplasmic extract (Figure 2B, lane 11). The
normal rabbit serum failed to precipitate hRrp4p from all three
extracts (Figure 2B, lanes 2, 6 and 10). Taken together, these
results indicate that MPP6 is a nuclear protein, which associ-
ates with the exosome in the nucleoli.
MPP6 co-sediments with nuclear exosome complexes
at 60S–80S in glycerol gradients
Previous reports have shown that human exosome core com-
ponents are in part associated with high molecular weight
complexes (1,12,13). To determine the size of MPP6-
associated complexes, nuclear and cytoplasmic extracts from
HEp-2 cells were fractionated by glycerol gradient sedimenta-
tion. Fractions were analysed by western blotting with rabbit
anti-MPP6, anti-hRrp4p and anti-PM/Scl-100 antisera and by
agarose gel electrophoresis to monitor the distribution of
RNA. The U1 snRNA was used as marker for 12S complexes,
whereas the large rRNAs were used to identify 40S and 60S
ribosomal subunits. The results in Figure 3 show that for the
cytoplasmic extract the majority of hRrp4p was present in
fractions 2–7 corresponding to  10S, whereas PM/Scl-100
and MPP6 were almost completely absent from these fractions
(Figure 3A). Interestingly, all three proteins, including MPP6
were detected in cytoplasmic 60S complexes, in spite of the
fact that the immunoﬂuorescence and immunoprecipitation
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Figure 1. Subcellular localization of MPP6.HEp-2cells were transfected with
constructsencodingEGFPalone(AandD),EGFP-MPP6(BandE)andEGFP-
hMtr3p (C and F) and after 24 h the cells were fixed in 4% paraformaldehyde/
PBS and the expressed fusion proteins were analysed by fluorescence micro-
scopy.Phase-contrastandfluorescenceimagesaredisplayedin(A–CandD–F),
respectively. Each bar corresponds to 10 mm.
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Figure 2. MPP6 is associated with nuclear exosome complexes. (A) HEp-2 cell extracts were subjected to immunoprecipitation with three anti-PM/Scl-positive
(lanes 1–3) and three anti-PM/Scl-negative patient sera (lanes 4–6). Precipitated proteins were analysed by western blotting using a rabbit anti-MPP6 serum. The
positionsofmolecularmassmarkers(kDa)areindicatedontheleft.(B)Reciprocalexperimentinwhichanormalrabbitserum(lanes2,6and10),apolyclonalanti-
MPP6serum(lanes3,7and11)andapolyclonalanti-hRrp40pserum(lanes4,8and12)wereusedforimmunoprecipitations.AmonoclonalantibodytohRrp4pwas
used for the detection of a co-precipitated exosome component. For the immunoprecipitations total (lanes 1–4), nuclear (lanes 5–8) and cytoplasmic (lanes 9–12)
HEp-2 cell extracts were used. Input material (10%) of the extracts was loaded in lanes 1, 5 and 9, respectively. The positions of molecular mass markers (kDa) are
indicated on the left.
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extract hRrp4p also sedimented in 10S complexes, but approx-
imately half of the nuclear hRrp4p molecules was found in
complexes corresponding to 60S–80Sas well (Figure 3B). The
majority of both PM/Scl-100 and MPP6 co-sedimented with
hRrp4p in 60S–80S fractions, whereas these proteins were
hardly or not detected at 10S. These data indicate that MPP6,
together with PM/Scl-100, is mainly associated with higher
molecular weight complexes in the nucleus.
Knock-down of MPP6 leads to accumulation of
5.8S rRNA precursors extended at the 30 end
The nucleolar accumulation ofMPP6,as wellasitsassociation
with pre-rRNA sized complexes in the nucleus suggested that
MPP6 might play a role in the biogenesis of ribosomes. Based
upon the situation in yeast, the precursor of rRNA has been
proposed to be one of the major substrates for the nuclear
exosome in human cells. In yeast it has been demonstrated
that the maturation of the 30 end of the 5.8S rRNA requires the
exosome, the exosome-associated TRAMP complex and sev-
eral other co-factors (3,5,6,18–20,30–33). To investigate the
role of MPP6 and the human exosome in the processing of pre-
rRNA, RNAi experiments were performed. siRNAs were
designed and synthesized for MPP6 and as a control, an
siRNA speciﬁc for a melanoma marker protein was included.
The effect of each MPP6–siRNA was assayed by transfection
of HEp-2 cells with each of these siRNAs and 2 days after
transfection protein as well as RNA was isolated. The efﬁci-
ency of MPP6 knock-down was assessed by western blotting.
A polyclonal antibody to hRrp41p was used as a control. The
results in Figure 4A show that all three MPP6-siRNAs led
to signiﬁcantly reduced levels of the MPP6 protein at 48 h
after transfection, while the levels of hRrp41p remained unaf-
fected (Figure 4A). Subsequently, RNA isolated from MPP6
siRNA-treated cells was analysed by gel electrophoresis and
northern blot hybridization using radiolabelled probes speciﬁc
for different regions of the pre-rRNA (Figure 4B). The results
demonstrate that knock-down of MPP6 leads to the accumu-
lation of 5.8S rRNA precursors, which hybridize with the
ITS2 probe in addition to the 5.8S coding sequence probe
(Figure 4B). These processing intermediates were not detected
with a probe speciﬁc for ITS1 (data not shown), which indic-
ates that the precursors accumulating upon MPP6 knock-down
are extended at their 30 end. Also, no accumulation of pro-
cessing intermediates was detected using the probes speciﬁc
for 50ETS (data not shown). Hybridization with a U6 snRNA
probe, which was used as a control, showed that there were no
signiﬁcant loading differences between the different samples
(Figure 4B, lanes 1–10). Note that under these conditions the
total amount of mature 5.8S rRNA was not signiﬁcantly
reduced.
Based upon the role of the exosome in the maturation of the
30 end of 5.8S rRNA in yeast and the association of MPP6 with
the exosome in the nucleus, we hypothesized that the observed
accumulation of processing intermediates resulting from
MPP6 knock-down might be due to the abrogation of the
function of the exosome. However, the effects of abrogation
of the function of the human exosome on 5.8S rRNA matura-
tion have not been documented so far. To shed more light on
this issue the effect of MPP6 RNAi on the 30 end of the 5.8S
rRNA was compared with those of knock down of the exo-
some components hRrp41p and PM/Scl-100 in an RNase pro-
tection assay. The reduction in protein levels was monitored
by western blotting, which indeed conﬁrmed the efﬁciency of
the siRNAs used (Figure 5A). The RNAs isolated from the
cells treated with the MPP6,hRrp41p andPM/Scl-100 siRNAs
were hybridized with a probe comprising the sequence com-
plementary to the most 50 300 nt of ITS2. After RNase diges-
tion, the reaction products were analysed by denaturing
PAGE (Figure 5B). Precursor RNAs detected in this experi-
ment were of similar size as those observed in the northern
Figure 3. MPP6 predominantly co-sediments with nuclear exosome complexes at 60S–80S in glycerol gradients. Cytoplasmic (A) and nuclear (B) extracts from
HEp-2 cells were fractionated in a 5–40% (v/v) glycerol gradient. The sedimentation of hRrp4, MPP6 and PM/Scl-100 was determined by immunoblotting. The
sedimentationofthelargerRNAswasdeterminedbyagarosegelelectrophoresisandethidiumbromidestainingandusedasmarkers(40Sand60S)inthegradient.U1
snRNA was used as marker for 12S complexes.
Nucleic Acids Research, 2005, Vol. 33, No. 21 6799blot hybridization. Note that low levels of precursor I were
observed also in the cells treated with the control siRNA,
whereas precursor II products were only detected for RNA
from MPP6 and exosome knock-down cells. The size of the
products of the RNase protection experiments indicated that
the 30 ends of the processing intermediates are located  156
and 250 nt downstream of the 30 end of the mature 5.8S rRNA.
Hybridization of the probe with yeast total RNA indicated that
the signals observed in lanes 2–5 are speciﬁc and not owing to
background signals resulting from self-complementary
sequences within the probe (lane 6).
MPP6 interacts with RNA in vitro and binds
preferentially to polypyrimidines
Theresultsoftheexperimentsdescribedabove suggestthatthe
exosome and MPP6 are involved in the same processing steps
in ITS2 to generate the mature 30 end ofthe human 5.8S rRNA.
This raises the question how they cooperate in this process.
The activities that are predicted to be involved are RNA-
binding for the recognition of processing sites in ITS2,
endoribonuclease activities for cleavage(s) in ITS2, 30!50
exoribonuclease for trimming of the cleaved precursor
RNA, and RNA helicase activities for resolving secondary
structures that interfere with nucleolytic processing. Several
exosome components have been shown to contain 30!50
exoribonuclease activity, but the recombinant MPP6 did not
appear to have such an activity (data not shown). The amino
acid sequence of MPP6 is also devoid of endoribonuclease and
helicase motifs. Therefore, we investigated whether MPP6 can
bind to RNA. GST pull-down experiments were performed
withGST-taggedMPP6 proteinandthreedistinct
32P-labelled,
in vitro transcribed RNAs, 5.8S rRNA, a transcript containing
part of the ITS2 and the RNA component of RNase MRP. As
shown in Figure 6A, GST-MPP6 bound to all three RNAs
efﬁciently (compare lanes 3 with the corresponding lanes
1), in contrast to GST, which did not precipitate any of the
RNAs (lanes 2). In addition, a GST pull-down experiment
using a HEp-2 cell extract showed that GST-MPP6 was
able to associate with RNAs in this extract including 5.8S
rRNA and 5.8S rRNA precursors (data not shown). These
data demonstrate that MPP6 does contain RNA-binding activ-
ity and suggest that the speciﬁcity of binding may be low. To
study this in more detail, a similar experiment was performed
with different radiolabelled homopolynucleotides. The results
showed that GST-MPP6 preferentially binds to poly(C) and
poly(U). No binding to poly(A) could be detected and the
relatively weak binding to poly(G) should be interpreted
with care, because also GST displayed some binding to
poly(G) and poly(G) is known to adopt higher order structures
which may affect background levels. GST-MPP6 also did not
appear to bind to poly(C)–poly(I), which was included as a
double-stranded RNA in these analyses (Figure 6B).
DISCUSSION
In this study we have characterized the previously identiﬁed
association of MPP6 with exosome complexes in human
cells. The association with the exosome was conﬁrmed by
co-immunoprecipitation experiments and shown to be restric-
ted to the nuclear compartment, more speciﬁcally the nucleoli.
In logarithmically growing HEp-2 cells the majority of MPP6
appeared to be associated with 60S–80S complexes which
most probably represent pre-ribosomes and knock-down
experiments indeed demonstrated that MPP6 participates,
Figure 4. Knock down of MPP6 by RNAi leads to the accumulation of 5.8S rRNA precursors. (A) HEp-2 cells were transiently transfected with three different
siRNAs to MPP6 (100 pmol), control siRNA or buffer (mock). Cells were harvested 2 days after transfection and 75 mg of total protein was analysed by western
blottingusingapolyclonalanti-MPP6serumorapolyclonalanti-hRrp41pserum(control).(B)Northernanalysisof5.8SrRNAprocessinguponMPP6knockdown.
TotalRNA(5mg)from(mock)transfectedcellswasanalysedbynorthernblothybridizationusingradiolabelledprobesspecificfor5.8SrRNA(left)orITS2(right).
The relative positions of these probes, and also the other probes used, with respect to the primary rRNA transcript are depicted in the scheme below the
autoradiographs. Note that the size of the probes is not proportional to that of the pre-rRNA. As a control, a U6 snRNA probe was used. The positions of
5.8SrRNAanditsprecursors(IandII)areindicated.Theasteriskintherightpanelpointstoaweakcross-hybridizationoftheITS2probewiththemature5.8SrRNA.
6800 Nucleic Acids Research, 2005, Vol. 33, No. 21in conjunction with the exosome, in the processing of human
pre-rRNA.
The association of MPP6 with the nuclear exosome
Although the highest concentrations of human core exosome
components can be detected in the nucleolus by immunoﬂuor-
escence microscopy, subcellular fractionation experiments
have shown that core exosome components are present in
both nuclear and cytoplasmic fractions (12,13,34–37). Similar
to other exosome components hMtr3p, the subcellular distri-
bution of which has not been described before, showed
a nuclear ﬂuorescence pattern, with an accumulation in the
nucleoli. MPP6 also displayed a subcellular localization which
is mainly restricted to the nucle(ol)us both by ﬂuorescence
microscopy and biochemical fractionation. The relatively low
level of co-precipitation of hRrp4p with anti-MPP6 in com-
parison with anti-hRrp40p from nuclear extracts indicated that
only a relatively small fraction of nuclear exosome complexes
is stably associated with MPP6. This is substantiated by the
results of co-immunoprecipitation experiments performed
with anti-EGFP antibodies using extracts from transiently
transfected HEp-2 cells expressing EGFP-tagged MPP6 or,
as a reference, EGFP-tagged hCsl4p (data not shown). Frac-
tionationofthenuclearextract byglycerolgradientsedimenta-
tion revealed that MPP6 is not associated with the low
molecular weight exosome complexes at  10S, but only asso-
ciates with the exosome complexes at 60S–80S. Also the
majority of PM/Scl-100 appeared to be associated with
60S–80S complexes in the nuclear extract.
In yeast, the exosome has been shown to function in pre-
rRNA, pre-sn(o)RNA and pre-mRNA processing and/or
degradation in the nucleus, whereas in the cytoplasm it is
involved in mRNA degradation (38). Currently, it is unclear
whether the small, though signiﬁcant fraction of MPP6, PM/
Scl-100 and hRrp4p molecules in the cytoplasmic extract that
sediment at 60S are associated with a cytoplasmic complex, or
whether this is due to some leakage of nuclear material to the
cytoplasm during preparation of the extracts. Interestingly, the
high molecular weight peak in the cytoplasmic material is
observed at 60S, whereas the peak with the nuclear material
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hybridizedto5mgoftotalRNAfromsiRNA-treatedcells.Afterdigestionwith
RNase A and RNase T1 the RNA was analysed on a 10% denaturing poly-
acrylamidegel.TheradiolabelledITS2probewasloadedinlane1.Asacontrol,
the same probe was incubated with 5 mg of yeast total RNA and further treated
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different complexes.
Because neither co-immunoprecipitation nor density gradi-
ent sedimentation data demonstrate a direct interaction of
MPP6 with the exosome, the possibility exists that other
proteins mediate their interaction, especially because it only
seems to occur in the large preribosomal complexes. The
results of an analysis of possible interactions between
MPP6 and exosome core components in a mammalian two-
hybrid system were all negative (G. Schilders and
G.J.M. Pruijn, unpublished data). However, yeast two-
hybrid data have suggested direct interactions of MPP6
with both PM/Scl-100 and hMtr4p (25). Moreover, all three
proteins have also been identiﬁed as components of the nuc-
leolar proteome (http://www.lamondlab.com/NOPdb/). There-
fore, it seems most probable that the interaction of MPP6 with
the exosome depends on its binding to PM/Scl-100, which is
believed to interact directly with the core of the exosome.
Still, the almost exclusive association of the MPP6 protein
with nuclear 60S–80S complexes strongly suggested that
MPP6 is speciﬁcally involved in the function of the exosome
in pre-rRNA processing. Indeed, we found that upon knock
down of MPP6 the maturation of 5.8S rRNA is affected. The
accumulation of the same processing intermediates in cells
with reduced levels of either MPP6 or the exosome compon-
ents hRrp41p and PM/Scl-100 provides further evidence that
they act in concert in these processing steps.
The role of MPP6 in the maturation of the
30 end of the 5.8S rRNA
Although the exosome complex has been shown to function in
a wide variety of RNA processing pathways, it is still largely
unknown how the exosome recognizes its different substrates
and how these substrates are subsequently subjected to either
precise 30 end processing or complete degradation. Most prob-
ably, other proteins, which transiently associate with the exo-
some, mediate the recruitment of the exosome to speciﬁc
substrate RNAs. In mammalian cells so far no evidence has
been presented for the involvement of the exosome in rRNA
processing pathways. Our data show for the ﬁrst time that the
human exosome, like the yeast exosome, is required for the
maturation of the 30 end of the 5.8S rRNA. Both the hRrp41p
and PM/Scl-100 proteins appeared to be involved in this pro-
cess. In yeast depletion of Rrp6p and core exosome compon-
ents (including Rrp41p) have distinct effects on pre-rRNA
processing, because their depletion leads to the accumulation
of different processing intermediates. Based upon these obser-
vations a hand-over mechanism was proposed, in which the
core exosome components remove ITS2 nucleotides up to a
position 30 nt beyond the 30 end of the 5.8S rRNA and Rrp6p
then takes over and processes most of the remaining ITS2
nucleotides (3,20). In contrast to the situation in yeast, our
data did not reveal differences in the accumulation of 5.8S
rRNA precursors after knocking down PM/Scl-100 or
hRrp41p. Although the functional activities of these proteins
may have changed over time, we believe that these differences
are more probably explained by the depletion of the whole
exosome from the site of processing. The accumulation of the
same processing intermediates after MPP6 knock down sup-
ports this idea. Furthermore, the observed accumulation of
distinct 5.8S intermediates indicates that there are endonuc-
leolytic cleavage sites within the human ITS2, which are not
affected by MPP6 or exosome knock down. These putative
cleavage sites are  156 and250ntdownstream ofthe 30 endof
the 5.8S rRNA coding sequence and might give rise to the 8S
and 12S pre-rRNAs observed previously in other mammalian
cells (39–41).
A database search did not reveal an MPP6 homologue in the
yeast Saccharomyces cerevisiae, but the amino acid sequence
Figure 7. Model for the role of MPP6 in pre-rRNA processing. Before, or
directly after cleavage of the pre-rRNA in ITS2 by a yet unknown endoribo-
nuclease, MPP6 binds to oligopyrimidine stretches in the ITS2 RNA and sub-
sequently recruits the PM/Scl-100-containing exosome and probably several
additional factors, like hMtr4p or an hMtr4p containing complex. This is in
agreement with the reported two-hybrid interactions between MPP6 and PM/
Scl-100andbetweenMPP6andhMtr4p(25).Theexosomewillthenprocessthe
ITS2 RNA to generate the mature 5.8S rRNA. MPP6 may either remain asso-
ciated with the processing complex or dissociate once the exosome starts the
digestion.
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charomyces pombe is a putative homologue of MPP6 (27%
identity; 39% similarity). This indicates that there might be
differences in pre-rRNA architecture between both yeast
strains which require at least in part distinct processing
machineries.
There are no known protein motifs that can be discerned in
the primary structure of MPP6 which could give a clue about
its function. The only sequence motif that can be discerned is a
bipartite nuclear localization signal (amino acid 116–132).
The bacterially expressed recombinant GST–MPP6 fusion
protein did not display 30!50 exoribonuclease activity
in vitro (G. Schilders and G.J.M. Pruijn, unpublished data).
However, our in vitro RNA-binding experiments show that
MPP6 is able to interact with the 5.8S-proximal ITS2 region of
pre-rRNA, and displays a binding preference for polypyrimi-
dines. Interestingly, the 30 end of the 5.8S precursor II, which
accumulates upon MPP6 knock down, contains an oli-
gopyrimidine tract ( 20 nt). The effects on pre-rRNA pro-
cessing suggest that MPP6 is an essential co-factor for the
exosome in the nucleolus. Nevertheless, our RNA-binding
data show that the binding speciﬁcity of MPP6 is low, imply-
ing that this protein may bind to various other RNAs and may
also be involved in the 30 end processing of other RNAs.
The reduction of MPP6 levels didnot signiﬁcantly affect the
expression levels or subcellular localization of exosome com-
ponents(datanotshown),indicatingthatMPP6isprobablynot
required for exosome assembly or for its subcellular targeting.
Taken together, our data support a model in which MPP6
mediates the recruitment of the exosome to the ITS2 for fur-
ther processing (Figure 7). The RNA-binding properties of
MPP6 suggest that MPP6 ﬁrst interacts with the pre-rRNA,
thereby creating a binding site for the PM/Scl-100-containing
exosome. The exosome subsequently processes ITS2, and at
this stage MPP6 may either remain associated or may be
released from the exosome at the start of the exonucleolytic
digestion. Recently, the Mtr4p-containing TRAMP complex
was shown to be involved in exosome-mediated pre-rRNA
processing in yeast (31–33). It would therefore be interesting
to investigate whether MPP6 also plays a role in the associ-
ation of the human counterpart of the TRAMP complex with
the pre-rRNA-exosome complex.
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